Become a Fellow of OMA
Introducing your newest benefit of membership -- apply now to become a Fellow of OMA! Becoming a Fellow allows you to stand out among your medical colleagues and demonstrate that you have the expertise to treat obesity effectively. To apply, ensure you meet the necessary criteria and complete an application. We will formally recognize and honor the new Fellows at Obesity Medicine 2017 next spring.
|
 |
Congratulations to Our 2016 Award Recipients
At Overcoming Obesity 2016, we presented awards to members who've gone above and beyond the call of duty this past year. We congratulate all of the 2016 award recipients!
|
| Harold Bays, MD, FTOS, FACE, FNLA
Obesity Medicine Clinician of the Year |  | Wendy Scinta, MD, MS
Dr. Vernon B. Astler Award |  | Carl Knopke, MD
Steelman-Seim Educator Award for Excellence in Academics |  | Amy Articolo, DO, FACOOG
Dr. Raymond E. Dietz Meritorious Service Award |  | Angela Fitch, MD, FACP
Dr. Peter G. Lindner Award |  | Suzanne Cuda, MD, FAAP
Committee Leadership Award |
This year, we also presented a new award in collaboration with the American Board of Obesity Medicine (ABOM). We congratulate Abby Bleistein, MD, who received the first-ever ABOM Candidate of the Year Award! View all of our current and past award recipients.
|
Participate in National Obesity Care Week
|
|
 Free Webcast: Reversing the 30-year Rise in Obesity and Type 2 Diabetes
The National Academy of Medicine will host a symposium and free live webcast on Oct. 17 titled, Reversing the Dramatic, 30-Year Rise in Obesity and Type 2 Diabetes. The symposium features keynote addresses by Margaret Chan, director of the World Health Organization, and Dr. William Dietz, director of obesity and prevention programs at George Washington University. The keynotes will examine both global and U.S. perspectives on the obesity epidemic. The symposium also features panel discussions on the drivers of obesity and type 2 diabetes, clinical interventions, and population-level strategies. Learn more or register online for the free webcast.
|
|
|
|
Executive Director
Sponsorships and Exhibits Manager
Operations Manager
Executive Director of the Obesity Treatment Foundation
|
|
101 University Blvd.,
Suite 330
Denver, CO 80206
|
|
|
 Submit an Abstract for the 5th Canadian Obesity Summit
The Canadian Obesity Network invites you to submit a research abstract for the upcoming 5th Canadian Obesity Summit in Banff, Alberta, next spring. The meeting takes place April 25-29, 2017, but abstract submission closes soon. Submit your abstract before Oct. 24.
|
Obesity Treatment Foundation
|
Congratulations to the 2016 Poster Contest Winner
Congratulations to the WOW Clinic from Orono, Maine, for winning the poster contest at Overcoming Obesity 2016! Authors Valerie O'Hara, DO; Nancy Browne, PNP, FAANP; Samreen Fathima, BDS, MPH; Starr Johnston, RN; Kathrin Hastey, FNP; Barbara Sorondo, MD, MBA; Janet Bayleran, PhD, won for their poster titled, " Obesity Metabolic Co-morbidities with Associated Disease Burden in Children and Adolescents."
|
|
Impact of Intragastric Balloon before Laparoscopic Gastric Bypass on Patients with Super Obesity: A Randomized Multicenter Study
Coffin, B., et al. Obesity Surgery, 2016.
The effect of an intragastric balloon (IGB) prior to laparoscopic gastric bypass (LGBP) was studied in patients with BMI > 45 kg/m2. In one group, the IGB was inserted and combined with standard medical care (SMC) for six months. This group was compared with a group only getting SMC. LGBP was then performed on all patients. At six months, weight loss was significantly greater in the IGB group than in the SMC group, and there were three severe complications during IGB removal. Mean operative time for LGBP was similar in both groups; however, five patients had surgical complications in the IGB group. Both groups had similar weight loss at 12 months. This study suggests that IGB insertion before LGBP does not improve peri-operative outcomes or post-operative weight loss. View article
|
|
Effect of GLP-1 Receptor Agonist Treatment on Body Weight in Obese Antipsychotic-treated Patients with Schizophrenia: A Randomized, Placebo-controlled Trial Byline
Ishoy, P. L., et al. Diabetes, Obesity and Metabolism, 2016.
Antipsychotics are the standard of care for schizophrenia, but the drugs are associated with obesity. A study was conducted to test the glucagon-like peptide-1 receptor agonist (GLP-1RA), exenatide once-weekly, in non-diabetic, antipsychotic-treated, patients with obesity and schizophrenia. Patients were randomized to receive either once-weekly subcutaneous exenatide (n = 23) or placebo (n = 22) injections for three months. Results showed that there were no group differences in weight loss (2.2 kg) after the intervention. These findings suggest that GLP-1RAs may not be effective in overcoming the obesity-promoting effects of antipsychotic medications in patients with obesity. View article
|
|
Preferred Descriptions for Loss of Control While Eating and Weight among Patients with Binge-Eating Disorder
Roberto, C. A., et al. Psychiatry Research, 2016.
A questionnaire was given to patients with binge-eating disorder (BED) to assess preferences for common loss of control descriptions and weight-related terms. Some patients with BED feel negatively judged when clinicians assess for loss of control, so identifying preferred terms is important for clinicians to build rapport with patients. Results from the questionnaire showed that the majority of common descriptors for loss of control eating were viewed neutrally, with "loss of control" being the most preferred term. Descriptions suggesting patients were addicted to food or did not consider stopping eating once they started binge-eating were viewed negatively. Participants indicated that they viewed the following terms negatively: "heaviness," "large size," "obesity," "excess fat," and "fatness." Terms such as "BMI" and "unhealthy body weight" were viewed more favorably. "Weight" was the most preferred term. These findings provide some guidance for health care providers to use when talking to patients with BED about eating and weight. View article
|
|
Join Us Next Spring: Obesity Medicine 2017 Is in Seattle from April 19-23!
We are excited to announce our upcoming conference, Obesity Medicine 2017 will be held in Seattle. Attend Obesity Medicine 2017 to gain practical knowledge on implementing the four treatment pillars, prepare for the ABOM certification exam, and gain a broader understanding of obesity and obesity-related conditions. Register online now! |
Review Course for the ABOM Exam (April 19-20)
Addresses the clinical topics physicians need to know for the American Board of Obesity Medicine (ABOM) certification exam.
Register Online
|
Essentials for Building a Sustainable Obesity Medicine Practice (April 19-20)
Focuses on essential topics to help you build and grow a sustainable obesity medicine practice.
Register Online
|
Spring Obesity Summit (April 21-23)
Offers you practical strategies for a wide range of patient cases and obesity-related conditions you may encounter in practice.
Register Online
|
|
|
Help Us Grow the Field with Obesity Medicine Basics
Obesity Medicine Basics is an introductory course to obesity medicine, perfect for health care professionals who are not familiar with the evidence-based methods of effectively treating obesity. Help us spread the word that the solution to obesity is NOT simply telling patients to "eat less and exercise more." You can help us ensure that all health care professionals have, at the very least, basic training in obesity medicine. Refer your colleagues and peers to Obesity Medicine Basics, happening in cities throughout the U.S. in 2017.
|
Dallas (January 14)
Embassy Suites Dallas Love Field
3880 W. Northwest Highway
Register Online
|
Los Angeles (January 21)
| Atlanta (February 4)
Omni Atlanta Hotel at CNN Center
100 CNN Center
Register Online
| Baltimore (February 18)
Embassy Suites Baltimore Inner Harbor
222 St. Paul Place
Register Online
|
|
|
|
|
The Obesity Medicine Association and the Obesity Treatment Foundation thank our 2016 Corporate Advisory Council members for their continuous support.
|
© 2016 Obesity Medicine Association. All rights reserved. Materials may not be reproduced, redistributed or translated without written permission. Advertising disclaimer: Under a policy approved by the OMA executive committee and exhibitor/advertiser review committee, commercial companies may apply to advertise in OMA publications. Approval does not imply endorsement or official recognition of particular products or services.
|
|
|
|
